202 related articles for article (PubMed ID: 12548712)
21. The substance P/neurokinin-1 receptor system in lung cancer: focus on the antitumor action of neurokinin-1 receptor antagonists.
Muñoz M; González-Ortega A; Rosso M; Robles-Frias MJ; Carranza A; Salinas-Martín MV; Coveñas R
Peptides; 2012 Dec; 38(2):318-25. PubMed ID: 23026680
[TBL] [Abstract][Full Text] [Related]
22. Neurokinin-1 and neurokinin-3 receptors in primate substantia nigra.
Lévesque M; Wallman MJ; Parent R; Sík A; Parent A
Neurosci Res; 2007 Mar; 57(3):362-71. PubMed ID: 17134780
[TBL] [Abstract][Full Text] [Related]
23. Neutrophil-specific chemokines are produced by astrocytic cells but not by neuronal cells.
Lu W; Maheshwari A; Misiuta I; Fox SE; Chen N; Zigova T; Christensen RD; Calhoun DA
Brain Res Dev Brain Res; 2005 Mar; 155(2):127-34. PubMed ID: 15804401
[TBL] [Abstract][Full Text] [Related]
24. Regulation of the NK-1 receptor gene expression in human macrophage cells via an NF-kappa B site on its promoter.
Simeonidis S; Castagliuolo I; Pan A; Liu J; Wang CC; Mykoniatis A; Pasha A; Valenick L; Sougioultzis S; Zhao D; Pothoulakis C
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2957-62. PubMed ID: 12594338
[TBL] [Abstract][Full Text] [Related]
25. Coexpression of preprotachykinin A and B transcripts in the bovine corpus luteum and evidence for functional neurokinin receptor activity in luteal endothelial cells and ovarian macrophages.
Brylla E; Aust G; Geyer M; Uckermann O; Löffler S; Spanel-Borowski K
Regul Pept; 2005 Feb; 125(1-3):125-33. PubMed ID: 15582723
[TBL] [Abstract][Full Text] [Related]
26. Aprepitant limits in vivo neuroinflammatory responses in a rhesus model of Lyme neuroborreliosis.
Martinez AN; Burmeister AR; Ramesh G; Doyle-Meyers L; Marriott I; Philipp MT
J Neuroinflammation; 2017 Feb; 14(1):37. PubMed ID: 28202084
[TBL] [Abstract][Full Text] [Related]
27. Full-length and truncated neurokinin-1 receptor expression and function during monocyte/macrophage differentiation.
Lai JP; Ho WZ; Kilpatrick LE; Wang X; Tuluc F; Korchak HM; Douglas SD
Proc Natl Acad Sci U S A; 2006 May; 103(20):7771-6. PubMed ID: 16675550
[TBL] [Abstract][Full Text] [Related]
28. Substance P differentially stimulates IL-8 synthesis in human corneal epithelial cells.
Tran MT; Lausch RN; Oakes JE
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3871-7. PubMed ID: 11053288
[TBL] [Abstract][Full Text] [Related]
29. Functional neurokinin NK-1 receptor expression in rat peritoneal mast cells.
Okada T; Hirayama Y; Kishi S; Miyayasu K; Hiroi J; Fujii T
Inflamm Res; 1999 May; 48(5):274-9. PubMed ID: 10391116
[TBL] [Abstract][Full Text] [Related]
30. Activation of the neurokinin-1 receptor by substance P triggers the release of substance P from cultured adult rat dorsal root ganglion neurons.
Tang HB; Li YS; Arihiro K; Nakata Y
Mol Pain; 2007 Dec; 3():42. PubMed ID: 18157919
[TBL] [Abstract][Full Text] [Related]
31. Substance P Promotes the Progression of Endometrial Adenocarcinoma.
Ma J; Yuan S; Cheng J; Kang S; Zhao W; Zhang J
Int J Gynecol Cancer; 2016 Jun; 26(5):845-50. PubMed ID: 27051050
[TBL] [Abstract][Full Text] [Related]
32. A role for the substance P/NK-1 receptor complex in cell proliferation in oral squamous cell carcinoma.
Brener S; González-Moles MA; Tostes D; Esteban F; Gil-Montoya JA; Ruiz-Avila I; Bravo M; Muñoz M
Anticancer Res; 2009 Jun; 29(6):2323-9. PubMed ID: 19528498
[TBL] [Abstract][Full Text] [Related]
33. Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus.
Remröd C; Lonne-Rahm S; Nordlind K
Arch Dermatol Res; 2007 May; 299(2):85-91. PubMed ID: 17370082
[TBL] [Abstract][Full Text] [Related]
34. Expression of substance P, neurokinin-1 receptor and immune markers in the brains of individuals with HIV-associated neuropathology.
Spitsin S; Stevens KE; Douglas SD
J Neurol Sci; 2013 Nov; 334(1-2):18-23. PubMed ID: 23916293
[TBL] [Abstract][Full Text] [Related]
35. Morphine upregulates functional expression of neurokinin-1 receptor in neurons.
Wan Q; Douglas SD; Wang X; Kolson DL; O'Donnell LA; Ho WZ
J Neurosci Res; 2006 Nov; 84(7):1588-96. PubMed ID: 16983662
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous allergic contact dermatitis responses are diminished in mice deficient in neurokinin 1 receptors and augmented by neurokinin 2 receptor blockage.
Scholzen TE; Steinhoff M; Sindrilaru A; Schwarz A; Bunnett NW; Luger TA; Armstrong CA; Ansel JC
FASEB J; 2004 Jun; 18(9):1007-9. PubMed ID: 15084523
[TBL] [Abstract][Full Text] [Related]
37. Expression of NK-1 receptor mRNA in murine T lymphocytes.
McCormack RJ; Hart RP; Ganea D
Neuroimmunomodulation; 1996; 3(1):35-46. PubMed ID: 8892359
[TBL] [Abstract][Full Text] [Related]
38. Detection of substance P and its receptor in human fetal microglia.
Lai JP; Zhan GX; Campbell DE; Douglas SD; Ho WZ
Neuroscience; 2000; 101(4):1137-44. PubMed ID: 11113362
[TBL] [Abstract][Full Text] [Related]
39. Evidence for spatial proximity of two distinct receptor regions in the substance P (SP)*neurokinin-1 receptor (NK-1R) complex obtained by photolabeling the NK-1R with p-benzoylphenylalanine3-SP.
Bremer AA; Leeman SE; Boyd ND
J Biol Chem; 2001 Jun; 276(25):22857-61. PubMed ID: 11294866
[TBL] [Abstract][Full Text] [Related]
40. Substance P stimulates late-stage rat osteoblastic bone formation through neurokinin-1 receptors.
Goto T; Nakao K; Gunjigake KK; Kido MA; Kobayashi S; Tanaka T
Neuropeptides; 2007 Feb; 41(1):25-31. PubMed ID: 17204323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
